Year
2023
-
CHMP recommends approval for GSK’s RSV vaccine candidate
-
National Institute for Health and Care Excellence approves expanded use of Yescarta and Tecartus
-
FDA approves drug which helps to slow progression of rare form of MND
-
Labeling error forces Teva to recall 13 lots of fentanyl buccal tablets
-
Danaher’s Aldevron unit plots mRNA manufacturing expansion
-
FDA turns back Ascendis’ hormone drug over manufacturing issues
-
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
-
AstraZeneca FDA vote worth potentially US$500mln annual peak sales
-
With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market
-
Sanofi signs agreement worth up to $750m for Maze’s Pompe disease drug